default author photo

Satawat Thongsawat

Chiang Mai University - Maharaj Nakorn Chiang Mai Hospital

Huay Kaew Road

Chiang Mai, Chiang Mai 50100

Thailand

SCHOLARLY PAPERS

2

DOWNLOADS

139

TOTAL CITATIONS

2

Scholarly Papers (2)

1.

Sofosbuvir/Velpatasvir for Treatment of Hepatitis C Virus in Asia: An Open-Label, Phase 3 Study

, Gastroenterology & Hepatology, Volume 4, Issue 2, P86-88, February 01, 2019, https://doi.org/10.1016/S2468-1253(18)30417-5
Number of pages: 127 Posted: 09 Oct 2018
Peking University - People’s Hospital, National University Hospital, Singapore - Department of Gastroenterology and Hepatology, Shanghai Jiao Tong University (SJTU) - Department of Infectious Diseases, National Hospital for Tropical Diseases, Songklanagarind Hospital, Central South University - Endocrinology Research Center, Fudan University - Shanghai Public Health Clinical Center, Guangzhou 8th People's Hospital, Sichuan University - West China Hospital, Capital Medical University - Beijing Ditan Hospital, National Hospital for Tropical Diseases, Jilin University (JLU), Jinan University, Mahidol University, China Medical University, Chiang Mai University - Maharaj Nakorn Chiang Mai Hospital, Hebei Medical University, National University of Singapore (NUS) - Singapore General Hospital, Huazhong University of Science and Technology - Department of Infectious Disease, Hospital Tengku Ampuan Afzan, Shanghai Jiao Tong University (SJTU), Shanghai Jiao Tong University (SJTU), Gilead Sciences, Inc., Gilead Sciences, Inc., Gilead Sciences, Inc., Gilead Sciences, Inc., Southeast University - The Second Hospital of Nanjing, Bach Mai Hospital, Peking University, Mahidol University, Chongqing University, Chulalongkorn University, Nanchang University, Sun Yat-sen University (SYSU), Hainan Provincial People's Hospital, 115 People's Hospital, Central South University - Second Xiangya Hospital, Central South University - Second Xiangya Hospital, Jiangsu Province People's Hospital, Guangxi Medical University, Capital Medical University, University of Malaya (UM), Southern Medical University - Nanfang Hospital and Capital Medical University
Downloads 72 (860,052)
Citation 1

Abstract:

Loading...

hepatitis C infection; NS5B polymerase inhibitor; NS5A inhibitor, Asia

2.

Efficacy and Safety of Ravidasvir Plus Sofosbuvir in Chronic Hepatitis C Infected Subjects Without Cirrhosis or with Compensated Cirrhosis: Interim Analysis Results of a Two-Stage, Open-Label, Multicentre, Phase 2/3 Trial

Number of pages: 28 Posted: 08 Dec 2020
Drugs for Neglected Diseases Initiative (DNDi), Selayang Hospital - Department of Hepatology, Ministry of Public Health - Department of Disease Control, Chiang Mai University - PHPT/IRD, Drugs for Neglected Diseases Initiative (DNDi), Drugs for Neglected Diseases Initiative (DNDi), Chiang Mai University - PHPT/IRD, Hospital Ampang - Department of Medicine/Gastroenterology, Hospital Sultanah Bahiyah - Department of Medicine/Gastroenterology, Hospital Selayang - Department of Hepatology, Hospital Tengku Ampuan Afzan - Department of Medicine/Gastroenterology, University of Malaya (UM) - Gastroenterology and Hepatology Unit, Hospital Sungai Buloh - Department of Medicine/Infectious Disease, Chiang Mai University - Maharaj Nakorn Chiang Mai Hospital, Nakornping Hospital, Thai Red Cross AIDS Research Centre, Bangkok, Bamrasnaradura Infectious Diseases Institute, Geneva University Hospitals and Faculty of Medicine - Laboratory of Virology, Chiang Mai University - PHPT/IRD, Drugs for Neglected Diseases Initiative (DNDi), Drugs for Neglected Diseases Initiative (DNDi), Drugs for Neglected Diseases Initiative (DNDi), Drugs for Neglected Diseases Initiative (DNDi), Drugs for Neglected Diseases Initiative (DNDi) and Ministry of Health Malaysia
Downloads 67 (899,324)
Citation 1

Abstract:

Loading...